STOCK TITAN

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CONMED (NYSE: CNMD) is set to release its financial results for the second quarter of 2024 on July 31, 2024, after the market close. A conference call to discuss these results will be hosted by the company's management at 4:30 p.m. ET on the same day. Investors can participate in the conference call by pre-registering to obtain the dial-in number and passcode. The call will also be webcast live on the 'Investors' section of CONMED's website, with a replay available approximately one hour after the call ends.

Positive
  • Announcement of financial results date for Q2 2024 ensures transparency.
  • Management's live discussion indicates confidence and engagement with investors.
Negative
  • None.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.

This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About CONMED Corporation

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

CONMED Corporation

Todd Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When will CONMED announce its Q2 2024 financial results?

CONMED will announce its Q2 2024 financial results on July 31, 2024, after the market close.

What time is the CONMED Q2 2024 earnings conference call?

The conference call for CONMED 's Q2 2024 earnings is scheduled for 4:30 p.m. ET on July 31, 2024.

How can investors participate in the CONMED Q2 2024 conference call?

Investors can participate by pre-registering to obtain the dial-in number and passcode. The call will also be webcast and accessible from the 'Investors' section of CONMED's website.

Where can I access the replay of CONMED 's Q2 2024 earnings call?

The replay of the Q2 2024 earnings call will be available on the 'Investors' section of CONMED's website approximately one hour after the call ends.

CONMED Corporation

NYSE:CNMD

CNMD Rankings

CNMD Latest News

CNMD Stock Data

2.17B
30.70M
0.58%
114.64%
7.66%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LARGO